A well-organized drug index is an invaluable tool, streamlining the search for specific pharmaceutical information and enhancing the speed and accuracy of decision-making in clinical, educational, and research settings.
RxReasoner offers comprehensive information on authorized and marketed pharmaceutical products globally.
| Product name | Countries | |
|---|---|---|
| LYBEREN | Cyprus | |
| LYBET | South Africa | |
| LYBROL | Croatia | |
| LYCIMOR | Ireland | |
| LYCLEAR | Australia, Ireland, Israel, Malta, United Kingdom | |
| LYCOFER | Nigeria | |
| LYCOMAZOLE | Hong Kong | |
| LYDASA | Estonia | |
| LYDERM | Canada | |
| LYDIAN | Brazil | |
| LYDISILKA | Estonia, Croatia, Ireland, Lithuania, Poland | |
| LYDOCAN | Singapore | |
| LYDOCON | Turkey | |
| LYDOL | Tunisia | |
| LYDONCOSIN | Hong Kong | |
| LYFLEX | Malta, United Kingdom | |
| LYFNUA | Estonia, Croatia, Ireland, Italy, Japan, Lithuania | |
| LYGABA | Singapore | |
| LYHEXINE | Hong Kong | |
| LYLADORM | South Africa | |
| LYLEQ | United States | |
| LYLLANA | United States | |
| LYLLAS | Brazil | |
| LYMEPAK | United States | |
| LYMPHOSEEK | Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom | |
| LYMUNIR | Turkey | |
| LYNDAVEL | Ecuador | |
| LYNLEY ED | New Zealand | |
| LYNLOR | United Kingdom | |
| LYNOZ | Brazil | |
| LYNOZID | Turkey | |
| LYNPARZA | Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States | |
| LYNSUNATE | Nigeria | |
| LYNSUNATE FORTE | Nigeria | |
| LYNTRIAXONE | Nigeria | |
| LYNXICLAV | Nigeria | |
| LYNZ | Croatia | |
| LYO-DROL | Malta | |
| LYOMEPRA | Turkey | |
| LYOMET | Poland | |
| LYPATHIA | Turkey | |
| LYPOSAR | Turkey | |
| LYPRALIN | Australia | |
| LYPRE | Turkey | |
| LYPTIMZIA | Ireland | |
| LYRACAINE | Canada | |
| LYREX | Hong Kong | |
| LYRIBASTAD | Austria, Finland | |
| LYRICA | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa | |
| LYRINEL | Ireland, United Kingdom, South Africa | |
| LYSAKARE | Austria, Estonia, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Poland, United Kingdom | |
| LYSANTIN | Malta | |
| LYSANXIA | France, Tunisia | |
| LYSIN | South Africa | |
| LYSO-SIX | France | |
| LYSOBACT | Nigeria | |
| LYSOCAPINE | Hong Kong | |
| LYSODREN | Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States | |
| LYSOMOL | Hong Kong | |
| LYSOSPRAY | Cyprus | |
| LYSTATE | Brazil | |
| LYSTEDA | United States | |
| LYSTHENON | Austria, Estonia, Lithuania, Malta, Romania, Turkey | |
| LYSTIN | Hong Kong | |
| LYSUGI | Brazil | |
| LYTECA | South Africa | |
| LYTGOBI | Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, United States | |
| LYTOS | France | |
| LYTRESCIO | Estonia, Lithuania | |
| LYUMJEV | Austria, Estonia, France, Croatia, Israel, Italy, Japan, Lithuania, Poland, Romania, United Kingdom, United States | |
| LYVAM | Croatia | |
| LYXIT | Romania | |
| LYXUMIA | Austria, Brazil, Cyprus, Estonia, Spain, Finland, Hong Kong, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom | |
| LYZA | United States | |
| LYZALON | Australia | |
| LYZBET | Austria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
